Superiority of intranasal over systemic administration of bioengineered soluble ACE2 for survival and brain protection against SARS-CoV-2 infection.

Hassler, Luise; Wysocki, Jan; Ahrendsen, Jared T; Ye, Minghao; Gelarden, Ian; Nicolaescu, Vlad; Tomatsidou, Anastasia; Gula, Haley; Cianfarini, Cosimo; Khurram, Nigar; Kanwar, Yashpal; Singer, Benjamin D; Randall, Glenn; Missiakas, Dominique; Henkin, Jack; Batlle, Daniel

Hassler, Luise; Wysocki, Jan; Ahrendsen, Jared T; Ye, Minghao; Gelarden, Ian; Nicolaescu, Vlad; Tomatsidou, Anastasia; Gula, Haley; Cianfarini, Cosimo; Khurram, Nigar; Kanwar, Yashpal; Singer, Benjamin D; Randall, Glenn; Missiakas, Dominique; Henkin, Jack; Batlle, Daniel.

bioRxiv ; 2022 Dec 06.

Article em En | MEDLINE | ID: mdl-36523403

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753780
https://dx.doi.org/10.1101/2022.12.05.519032

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753780
https://dx.doi.org/10.1101/2022.12.05.519032

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article